Tran-Gia Johannes, Denis-Bacelar Ana M, Ferreira Kelley M, Robinson Andrew P, Calvert Nicholas, Fenwick Andrew J, Finocchiaro Domenico, Fioroni Federica, Grassi Elisa, Heetun Warda, Jewitt Stephanie J, Kotzassarlidou Maria, Ljungberg Michael, McGowan Daniel R, Scott Nathaniel, Scuffham James, Gleisner Katarina Sjögreen, Tipping Jill, Wevrett Jill, Lassmann Michael
Department of Nuclear Medicine, University of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
National Physical Laboratory, Teddington, UK.
EJNMMI Phys. 2021 Jul 23;8(1):55. doi: 10.1186/s40658-021-00397-0.
Patient-specific dosimetry is required to ensure the safety of molecular radiotherapy and to predict response. Dosimetry involves several steps, the first of which is the determination of the activity of the radiopharmaceutical taken up by an organ/lesion over time. As uncertainties propagate along each of the subsequent steps (integration of the time-activity curve, absorbed dose calculation), establishing a reliable activity quantification is essential. The MRTDosimetry project was a European initiative to bring together expertise in metrology and nuclear medicine research, with one main goal of standardizing quantitative Lu SPECT/CT imaging based on a calibration protocol developed and tested in a multicentre inter-comparison. This study presents the setup and results of this comparison exercise.
The inter-comparison included nine SPECT/CT systems. Each site performed a set of three measurements with the same setup (system, acquisition and reconstruction): (1) Determination of an image calibration for conversion from counts to activity concentration (large cylinder phantom), (2) determination of recovery coefficients for partial volume correction (IEC NEMA PET body phantom with sphere inserts), (3) validation of the established quantitative imaging setup using a 3D printed two-organ phantom (ICRP110-based kidney and spleen). In contrast to previous efforts, traceability of the activity measurement was required for each participant, and all participants were asked to calculate uncertainties for their SPECT-based activities.
Similar combinations of imaging system and reconstruction lead to similar image calibration factors. The activity ratio results of the anthropomorphic phantom validation demonstrate significant harmonization of quantitative imaging performance between the sites with all sites falling within one standard deviation of the mean values for all inserts. Activity recovery was underestimated for total kidney, spleen, and kidney cortex, while it was overestimated for the medulla.
This international comparison exercise demonstrates that harmonization of quantitative SPECT/CT is feasible when following very specific instructions of a dedicated calibration protocol, as developed within the MRTDosimetry project. While quantitative imaging performance demonstrates significant harmonization, an over- and underestimation of the activity recovery highlights the limitations of any partial volume correction in the presence of spill-in and spill-out between two adjacent volumes of interests.
为确保分子放射治疗的安全性并预测疗效,需要进行针对患者的剂量测定。剂量测定涉及多个步骤,第一步是确定随时间推移器官/病变摄取的放射性药物的活度。由于不确定性会在后续每个步骤(时间-活度曲线积分、吸收剂量计算)中传播,因此建立可靠的活度定量至关重要。MRTDosimetry项目是一项欧洲倡议,旨在汇集计量学和核医学研究方面的专业知识,其主要目标之一是基于在多中心比对中开发和测试的校准方案,实现基于镥的SPECT/CT定量成像的标准化。本研究介绍了此次比对活动的设置和结果。
此次比对包括九个SPECT/CT系统。每个站点使用相同的设置(系统、采集和重建)进行一组三次测量:(1)确定从计数转换为活度浓度的图像校准(大圆柱体模),(2)确定用于部分容积校正的恢复系数(带有球体插入物的IEC NEMA PET体模),(3)使用3D打印的双器官体模(基于ICRP110的肾脏和脾脏)验证已建立的定量成像设置。与之前的努力不同,要求每个参与者的活度测量具有可追溯性,并要求所有参与者计算其基于SPECT的活度的不确定性。
成像系统和重建的相似组合会导致相似的图像校准因子。拟人化体模验证的活度比结果表明,各站点之间的定量成像性能有显著的一致性,所有站点的结果都在所有插入物平均值的一个标准差范围内。全肾、脾脏和肾皮质的活度恢复被低估,而髓质的活度恢复被高估。
这项国际比对活动表明,按照MRTDosimetry项目中制定的专用校准方案的非常具体的说明进行操作时,定量SPECT/CT的一致性是可行的。虽然定量成像性能显示出显著的一致性,但活度恢复的高估和低估突出了在两个相邻感兴趣体积之间存在溢入和溢出的情况下,任何部分容积校正的局限性。